Investigation of antihypoxic properties of short peptides
Kozina LS · 2008 · Advances in gerontology = Uspekhi gerontologii 21(1):61-67. PMID 18546825
What does this source report?
The comparative report describes antihypoxic activity, with the largest effect for Pinealon in the tested model.
- Population and setting
- Experimental hypobaric/prenatal hypoxia models
- Evidence type
- Animal / experimental
- Preparation
- Synthetic peptide / defined-sequence research
- Source language
- English abstract; see original for language
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Model-specific ranking cannot be transferred to humans or occupational exposure protection.
- Full methods, adverse-event reporting and independent replication remain to be appraised.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Europe PMC indexed citation and abstract checked. Full original paper not reviewed.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Source provenance: Journal publication
Cite and trace this record
Original source: Kozina LS. Investigation of antihypoxic properties of short peptides Advances in gerontology = Uspekhi gerontologii 21(1):61-67. PMID 18546825 2008.
Molekul research summary: https://molekul.io/research/kh-18546825. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pinealon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Vesugen
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Vilon
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
Epitalon
AEDG was detected in pineal complex, but the long-term Epithalamin patient studies concern the extract. Synthetic-peptide effects require their own evidence.